##### § 1321.01 DEA mailing addresses. #####

The following table provides information regarding mailing addresses to be used when sending specified correspondence to the Drug Enforcement Administration.

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Code of Federal Regulations Section—Topic                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                                                                                                    DEA mailing address                                                                                                                                                                                                                                                                                                                                                    |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            **DEA Administrator**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1308.43(b)—Petition to initiate proceedings for rulemaking.  <br/>1316.23(b)—Petition for grant of confidentiality for research subjects.  <br/>1316.24(b)—Petition for exemption from prosecution for researchers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                           Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      **DEA Diversion Control Division**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1307.03—Exception request filing.  <br/>1307.22—Delivery of surrendered and forfeited controlled substances.  <br/>1310.21(b)—Sale by Federal departments or agencies of chemicals which could be used to manufacture controlled substances certification request.<sup>2</sup>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                                                   Drug Enforcement Administration, Attn: Diversion Control Division/DC, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                                    |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          **DEA Regulatory Section**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|1301.71(d)—Security system compliance review for controlled substances.  <br/>1309.71(c)—Security system compliance review for List I chemicals.  <br/>1310.03(c)—Mail-Order reports involving transactions with nonregulated persons or exports.<sup>1</sup>  <br/>1310.05(b)(1)—Unusual or excessive loss or disappearance of listed chemicals.  <br/>1310.05(b)(2)—Reports of domestic regulated transactions in a tableting machine or an encapsulating machine.<sup>1</sup>  <br/>1310.05(c)(1)—Reports of imports and exports of a tableting machine or an encapsulating machine.<sup>1</sup>  <br/>1310.05(c)(2)—Report of declared exports of machines refused, rejected, or returned.  <br/>1312.12(a)—Application for import permit (DEA Form 357).<sup>1</sup>  <br/>1312.18(b)—Import declaration (DEA Form 236) submission.<sup>1</sup>  <br/>1312.22(g)(8)—Request for return of unacceptable or undeliverable exported controlled substances.<sup>1</sup>  <br/>1312.27(a)—Controlled substances export declaration (DEA Form 236) filing.<sup>1</sup>  <br/>1312.31(b)—Controlled substances transshipment permit application.  <br/>1312.32(a)—Advanced notice of importation for transshipment or transfer of controlled substances.  <br/>1313.12(b)—Authorization to import listed chemicals (DEA Form 486/486A).<sup>1</sup>  <br/>1313.12(e)—Quarterly reports of listed chemicals importation.  <br/>1313.21(b)—Authorization to export listed chemicals (DEA Form 486).<sup>1</sup>  <br/>1313.21(e)—Quarterly reports of listed chemicals exportation.  <br/>1313.22(c)—Notice of declared exports of listed chemicals refused, rejected or undeliverable.<sup>1</sup>  <br/>1313.31(b)—Advanced notice of importation for transshipment or transfer of listed chemicals.  <br/>1313.32(b)(1)—International transaction authorization (DEA Form 486).<sup>1</sup>  <br/>1314.110(a)(1)—Reports for mail-order sales.  <br/>1314.110(a)(2)—Request to submit mail-order sales reports.|                                                                                                                                                                                                                                                                                                       Drug Enforcement Administration, Attn: Regulatory Section/DRG, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **DEA Drug & Chemical Evaluation Section**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1308.21(a)—Exclusion of nonnarcotic substance.  <br/>1308.23(b)—Exemption for chemical preparations.  <br/>1308.24(d)—Exempt narcotic chemical preparations importer/exporter reporting.  <br/>1308.24(i)—Exempted chemical preparations listing.  <br/>1308.25(a)—Exclusion of veterinary anabolic steroid implant product application.  <br/>1308.26(a)—Excluded veterinary anabolic steroid implant products listing.  <br/>1308.31(a)—Exemption of a nonnarcotic prescription product application.  <br/>1308.32—Exempted prescription products listing.  <br/>1308.33(b)—Exemption of certain anabolic steroid products application.  <br/>1308.34—Exempted anabolic steroid products listing.  <br/>1310.13(b)—Exemption for chemical preparations.  <br/>1310.05(d)—Bulk manufacturer of listed chemicals reporting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                               Drug Enforcement Administration, Attn: Drug & Chemical Evaluation Section/DRE, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       **UN Reporting & Quota Section**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1303.12(b)—Application for controlled substances procurement quota (DEA Form 250) filing and request.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |                                                                                                                                                                                                                                                                                                  Drug Enforcement Administration, Attn: UN Reporting & Quota Section/DRQ, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                                  |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1303.12(d)—Controlled substances quota adjustment request.  <br/>1303.22—Application for individual manufacturing quota (DEA Form 189) filing and request for schedule I or II controlled substances.  <br/>1304.31(a)—Manufacturers importing narcotic raw material report submission.  <br/>1304.32(a)—Manufacturers importing coca leaves report submission.  <br/>1315.22—Application for individual manufacturing quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 189) filing and request.  <br/>1315.32(e)—Application for procurement quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 250) filing and request.  <br/>1315.32(g)—Procurement quota adjustment request for ephedrine, pseudoephedrine, and phenylpropanolamine.  <br/>1315.34(d)—Application for import quota for ephedrine, pseudoephedrine, phenylpropanolamine (DEA Form 488) request and filing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1315.36(b)—Request import quota increase for ephedrine, pseudoephedrine, or phenylpropanolamine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **Pharmaceutical Investigations Section**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1304.04(d)—ARCOS separate central reporting identifier request.  <br/>1304.33(a)—Reports to ARCOS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                          Drug Enforcement Administration, Attn: ARCOS Unit/DOPT, P.O. Box 2520, Springfield, VA 22152-2520 OR Drug Enforcement Administration, Attn: ARCOS Unit, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         **DEA Registration Section**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 1301.03—Procedures information request (controlled substances registration)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |Drug Enforcement Administration, Attn: Registration Section/DRR P.O. Box 2639, Springfield, VA 22152.  <br/>1301.13(e)(2)—Request DEA Forms 224, 225, and 363.  <br/>1301.14(a)—Controlled substances registration application submission.  <br/>1301.18(c)—Research project controlled substance increase request.  <br/>1301.51—Controlled substances registration modification request.  <br/>1301.52(b)—Controlled substances registration transfer request.  <br/>1301.52(c)—Controlled substances registration discontinuance of business activities notification.  <br/>1309.03—List I chemicals registration procedures information request.  <br/>1309.33(a)—List I chemicals registration application submission.|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1309.61—List I chemicals registration modification request                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            **DEA Hearing Clerk**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1301.43—Request for hearing or appearance; waiver.  <br/>1303.34—Request for hearing or appearance; waiver.  <br/>1308.44—Request for hearing or appearance; waiver.  <br/>1316.45—Hearings documentation filing.  <br/>1316.46(a)—Inspection of record.  <br/>1316.47(a)—Request for hearing.  <br/>1316.48—Notice of appearance.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |                                                                                                                                                                                                                                                                                                         Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, VA 22152.                                                                                                                                                                                                                                                                                                         |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **DEA Federal Register Representative**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1301.33(a)—Filing of written comments regarding application for bulk manufacture of Schedule I and II substances.<sup>2</sup>  <br/>1301.34(a)—Filing of written comments regarding application for importation of Schedule I and II substances.<sup>2</sup>  <br/>1303.11(c)—Filing of written comments regarding notice of an aggregate production quota.<sup>2</sup>  <br/>1303.13(c)—Filing of written comments regarding adjustments of aggregate production quotas.<sup>2</sup>  <br/>1303.13(c)—Filing of written comments regarding adjustments of aggregate production quotas.<sup>2</sup>  <br/>1308.43(g)—Filing of written comments regarding initiation of proceedings for rulemaking.<sup>2</sup>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |                                                                                                                                                                                                                                                                               Drug Enforcement Administration, Attn: Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, VA 22152.  <br/>http://www.regulations.gov/.                                                                                                                                                                                                                                                                               |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              <sup>1</sup> Applications/filings/reports are required to be filed electronically in accordance with this chapter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    <sup>2</sup> Applications/filings/reports may be filed electronically in accordance with this chapter.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

[81 97041, Dec. 30, 2016, as amended at 87 FR 21023, Apr. 11, 2022]